Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
11.70
-0.50 (-4.10%)
At close: Jul 2, 2024, 4:00 PM
11.96
+0.26 (2.22%)
After-hours: Jul 2, 2024, 6:27 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $701.64 million as of July 2, 2024. Its market cap has increased by 972.84% in one year.
Market Cap
701.64M
Enterprise Value
393.04M
1-Year Change
972.84%
Ranking
Category
Stock Price
$11.70
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $701.64M, an increase of 529.89%. That is a compound annual growth rate of 63.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 701.60M | 53.46% |
| Dec 29, 2023 | 457.20M | 1,605.97% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.80M | 53.73% |
| Dec 31, 2020 | 102.00M | -8.43% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 749.74M |
| CureVac | 746.94M |
| Harrow Health | 744.79M |
| Cytek Biosciences | 736.44M |
| CARGO Therapeutics | 733.79M |
| Stoke Therapeutics | 722.91M |
| HilleVax | 716.98M |
| Ginkgo Bioworks Holdings | 714.69M |